María Gabriela Mediavilla

María Gabriela Mediavilla

Auto-generated profile, based on publicly available information

María Gabriela Mediavilla

Instituto de Biología Molecular y Celular de Rosario (IBR-CONICET-UNR), Ocampo y Esmeralda, Rosario 2000, Argentina

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Cryobiology
Verified
Journal Article
Closed access
JRJoaquı́n V. Rodrı́guez
Joaquı́n V. Rodrı́guez
MMMarı́a E. Mamprin
Marı́a E. Mamprin
MMMarı́a G. Mediavilla
Marı́a G. Mediavilla
EGEdgardo E. Guibert
Edgardo E. Guibert

7 December 1999 in FEBS Letters
Verified
Journal Article
Closed access
MMMaria Gabriela Mediavilla
Maria Gabriela Mediavilla
Lorella PascoloLorella Pascolo
Lorella Pascolo
JRJoaquin V. Rodriguez
Joaquin V. Rodriguez
EGEdgardo E. Guibert
Edgardo E. Guibert
JOJ.DOnald Ostrow
J.DOnald Ostrow
CTClaudio Tiribelli
Claudio Tiribelli

31 October 2022 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
RCRenzo Carlucci
Renzo Carlucci
GGGabriel Di Gresia
Gabriel Di Gresia
MMMaría Gabriela Mediavilla
María Gabriela Mediavilla
JCJulia Alejandra Cricco
Julia Alejandra Cricco
BTBabu L. Tekwani
Babu L. Tekwani
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
We have previously shown that prenyl and aliphatic triazoles are interesting motifs to prepare new chemical entities for antiparasitic and antituberculosis drug development. In this opportunity a new series of prenyl-1,2,3-triazoles were prepared from isoprenyl azides and different alkynes looking for new antimalarial drug candidates. The compounds were prepared by copper(I) catalyzed dipolar cycloaddition of the isoprenyl azide equilibrium mixture providing exclusively 1,4-disubstituted 1,2,3-triazoles in a regiospecific fashion. The complete collection of 64 compounds was tested on chloroquine-sensitive (CQ sensitive), Sierra Leone (D6), and the chloroquine-resistant, Indochina (W2), strains of Plasmodium falciparum and those compounds which were not previously reported were also tested against Leishmania donovani, the causative agent for visceral leishmaniasis. Thirteen analogs displayed antimalarial activity with IC50 below 10 μM, while the antileishmanial activity of the newly reported analogs could not improve upon those previously reported. Compounds 1o and 1r were identified as the most promising antimalarial drug leads with IC50 below 3.0 μM for both CQ-sensitive and resistant P. falciparum strains with high selectivity index. Finally, a chemoinformatic in silico analysis was performed to evaluate physicochemical parameters, cytotoxicity risk and drug score. The validation of a bifunctional farnesyl/geranylgeranyl diphosphate synthase PfFPPS/GGPPS as the potential target of the antimalarial activity of selected analogs should be further investigated.

1 March 2002 in Cell Transplantation
Verified
Journal Article
Open access
SSSilvana V. Spinelli
Silvana V. Spinelli
JRJoaquín V. Rodríguez
Joaquín V. Rodríguez
AQAlejandra B. Quintana
Alejandra B. Quintana
MMMaría G. Mediavilla
María G. Mediavilla
EGEdgardo E. Guibert
Edgardo E. Guibert
Hepatocellular transplant may potentially be efficacious for the treatment of selected liver metabolic disorders and acute hepatic failure. On the other hand, the use of hepatocyte cold preservation techniques in these transplantation protocols would allow to have available cells at the right time and place and, consequently, make an optimal use of scarce human hepatocytes. In our experiments we evaluated the biodistribution and functionality of cold preserved hepatocytes transplanted in the spleen of syngeneic rats. Isolated hepatocytes were labeled with the fluorescent dye 5(6)-carboxyfluorescein diacetate succinimidyl-ester, cold-preserved in modified University of Wisconsin (UW) solution for 48 or 96 h, and then transplanted into the spleen. Recipient animals were euthanized at 0 and 3 h, and at 1, 2, 3, 5, 10, and 14 days after transplantation for tissue analysis. Labeled hepatocytes were clearly identifiable in the recipient tissues up to 14 days later. Fluorescence microscopy also showed no significant differences in biodistribution when either cold stored or freshly isolated hepatocytes were transplanted. In addition, functional activity of transplanted cells was demonstrated by immunohistochemical detection of albumin at levels comparable to those found in normal hepatocytes. Our findings establish that cold preserved hepatocytes appear morphologically and biochemically normal after intrasplenic transplantation. Consequently, it indicates that modified UW solution makes it possible to safety preserve hepatocytes for up to 96 h before transplantation, perhaps providing sufficient time for hepatocyte allocation and potential recipient preparation, if applicable clinically.

19 October 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMaría G. Mediavilla
María G. Mediavilla
GVGisela A. Di Venanzio
Gisela A. Di Venanzio
EGEdgardo E. Guibert
Edgardo E. Guibert
CTClaudio Tiribelli
Claudio Tiribelli
Ferredoxin-NADP(H) reductase (FNR) from Pisum sativum and Flavodoxin (Fld) from Anabaena PCC 7119 have been reported to protect a variety of cells and organisms from oxidative insults. In this work, these two proteins were expressed in mitochondria of Cos-7 cells and tested for their efficacy to protect these cells from oxidative stress in vitro. Cos-7/pFNR and Cos-7/pFld cell lines expressing FNR and Fld, respectively, showed a significantly higher resistance to 24 h exposure to 300–600 µM hydrogen peroxide measured by LDH retention, MTT reduction, malondialdehyde (MDA) levels and lipid peroxide (LPO; FOX assay) levels. However, FNR and Fld did not exhibit any protection at shorter incubation times (2 h and 4 h) to 4 mM hydrogen peroxide or to a 48 h exposure to 300 µM methyl viologen. We found enhanced methyl viologen damage exerted by FNR that may be due to depletion of NADPH pools through NADPH-MV diaphorase activity as previously observed for other overexpressed enzymes. The results presented are a first report of antioxidant function of these heterologous enzymes of vegetal and cyanobacterial origin in mammalian cells.

1 October 2004 in Cell Transplantation
Verified
Journal Article
Open access
VSValeria Sigot
Valeria Sigot
MMMaría G. Mediavilla
María G. Mediavilla
GFGraciela Furno
Graciela Furno
JRJoaquín V. Rodríguez
Joaquín V. Rodríguez
EGEdgardo E. Guibert
Edgardo E. Guibert
Transplanted hepatocytes integrate, survive, and express their specific functions in the liver parenchyma. The aim of this study was to determine whether a large number of hepatocytes could move from the spleen to the liver when the cells are injected together with sodium nitroprusside, and if the improved hepatocyte migration may be related with portal vein dilatation. Wistar rats were transplanted in the spleen with fluorescent-labeled hepatocytes alone or together with sodium nitroprusside. At 1, 3, 6, and 24 h after the transplant, the liver from recipient animals was removed and morphometric analyses were performed. Portal and arterial pressures were also measured immediately after intrasplenic injection of a solution of sodium nitroprusside, hepatocytes alone, or hepatocytes plus sodium nitroprusside. Intrasplenically injected sodium nitroprusside produced a transient drop in arterial pressure and a sustained reduction in portal pressure. During hepatocyte transplantation it increased the number of transplanted cells migrating to the liver after 3 h. Sodium nitroprusside simultaneously injected with hepatocytes in the spleen allowed more cells to migrate into the liver of the host animal without risk in animal survival.